Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News RVL Pharmaceuticals PLC RVLPQ

Healthcare Biotechnology
RVL Pharmaceuticals plc is a pharmaceutical company focused on developing and commercializing eye care and medical aesthetics products. The Company is focused on developing and commercializing products for an underserved patient population in ocular medicine and medical aesthetics. It operates in one business segment which focuses on developing and commercializing pharmaceutical products. The... see more

Recent & Breaking News (GREY:RVLPQ)

RVL Completes Financial Restructuring

GlobeNewswire November 27, 2023

RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries

GlobeNewswire October 12, 2023

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire August 23, 2023

RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewswire August 16, 2023

RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review

GlobeNewswire August 14, 2023

RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update

GlobeNewswire August 2, 2023

RVL Pharmaceuticals plc Provides Business Update

GlobeNewswire July 5, 2023

RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting

GlobeNewswire June 15, 2023

RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update

GlobeNewswire May 11, 2023

RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update

GlobeNewswire May 4, 2023

RVL Pharmaceuticals Announces that Upneeq® Wins "Best Eye Drop for Drooping Lids" NewBeauty in 13th Annual Beauty Awards

GlobeNewswire April 3, 2023

RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Commercial Update

GlobeNewswire March 20, 2023

RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Commercial Update

GlobeNewswire March 15, 2023

RVL Pharmaceuticals plc Announces Preliminary Fourth Quarter Sequential Growth of 21% and Full Year 2022 UPNEEQ® Net Product Sales

GlobeNewswire January 9, 2023

RVL Pharmaceuticals plc to Present at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference

GlobeNewswire December 1, 2022

RVL Pharmaceuticals plc Reports Third Quarter 2022 Financial Results; Provides Commercial Update

GlobeNewswire November 10, 2022

RVL Pharmaceuticals plc to Discuss Third Quarter 2022 Financial Results and Provide Commercial Update

GlobeNewswire November 3, 2022

RVL Pharmaceuticals plc Announces Preliminary Third Quarter 2022 UPNEEQ® Net Product Sales

GlobeNewswire October 18, 2022

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment Conference

GlobeNewswire August 30, 2022

Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc

GlobeNewswire August 30, 2022